- Closed-loop TMS for Tremor — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT07574164.
- What is being tested: Phase-locked transcranial magnetic stimulation (TMS) delivered in synchronisation with tremor oscillations as a non-invasive treatment approach for tremor in Essential Tremor and Parkinson's Disease patients.
- Patient eligibility overview: The study includes adults with clinically diagnosed Essential Tremor or Parkinson's Disease who experience tremor symptoms; specific inclusion/exclusion criteria would typically exclude those with contraindications to TMS (e.g. metallic implants, seizure history) and severe cognitive impairment.
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
This study investigates the potential of phase-locked transcranial magnetic stimulation (TMS) as a non-invasive intervention for tremor in patients with Essential Tremor (ET) and Parkinson's Disease (PD). Tremor is a prevalent symptom that significantly impacts physical function and social participation. ET affects approximately 1% of the global population and worsens with age, while PD tremor is often less responsive to conventional dopaminergic therapy. Current treatments, including oral medications (propranolol, primidone), anticholinergics, and deep brain stimulation (DBS), are either limited by efficacy, side effects, or invasiveness. These challenges highlight the need…
- : * having either essential tremor or Parkinson's disease
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.